Education
About Us
Working with TipRanks
Follow Us
Organon (OGN)
NYSE:OGN
OGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.47 - $23.10
Previous CloseN/A
Volume728.75K
Average Volume (3M)3.96M
Market Cap
$3.23B
Enterprise Value$12.24B
Total Cash (Recent Filing)$675.00M
Total Debt (Recent Filing)$8.88B
Price to Earnings (P/E)3.8
Beta0.67
Next Earnings
May 01, 2025EPS Estimate
0.92Last Dividend Ex-Date
Feb 24, 2025Dividend Yield9.61%
Share Statistics
EPS (TTM)3.33
Shares Outstanding257,950,130
10 Day Avg. Volume3,341,457
30 Day Avg. Volume3,956,144
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)N/A
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)2.50
P/FCF Ratio2.40
Enterprise Value/Market Cap3.79
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.29
Enterprise Value/Ebitda7.41
Forecast
1Y Price Target
$19.00Price Target Upside63.09% Upside
Rating ConsensusHold
Number of Analyst Covering6
---
Organon News
PremiumCompany Announcements
Organon & Co. Navigates Growth Amidst Challenges
---
Bulls Say, Bears Say
Bulls Say
Product ApprovalManagement noted that VTAMA AD approval could come a little early, which could represent incremental product sales upside.
Product DevelopmentNexplanon is expected to surpass $1B in sales, with zero pregnancies in high BMI patients raising the bar for generics.
Bears Say
Currency ImpactWith 75% of revenue ex-US, a strengthening USD could create a currency headwind.
Financial GuidanceEBITDA guidance was lowered mostly because of increased IPR&D expenses.
---
Ownership Overview
0.25% Insiders
21.55% Mutual Funds
17.53% Other Institutional Investors
29.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OGN FAQ
What was Organon’s price range in the past 12 months?
Organon lowest stock price was $11.47 and its highest was $23.10 in the past 12 months.
What is Organon’s market cap?
Organon’s market cap is $3.23B.
When is Organon’s upcoming earnings report date?
Organon’s upcoming earnings report date is May 01, 2025 which is in 21 days.
How were Organon’s earnings last quarter?
Organon released its earnings results on Feb 13, 2025. The company reported $0.9 earnings per share for the quarter, beating the consensus estimate of $0.867 by $0.033.
Is Organon overvalued?
According to Wall Street analysts Organon’s price is currently Undervalued.
Does Organon pay dividends?
Organon pays a Quarterly dividend of $0.28 which represents an annual dividend yield of 9.61%. See more information on Organon dividends here
What is Organon’s EPS estimate?
Organon’s EPS estimate is 0.92.
How many shares outstanding does Organon have?
Organon has 257,950,130 shares outstanding.
What happened to Organon’s price movement after its last earnings report?
Organon reported an EPS of $0.9 in its last earnings report, beating expectations of $0.867. Following the earnings report the stock price went up 11.019%.
Which hedge fund is a major shareholder of Organon?
Currently, no hedge funds are holding shares in OGN
---
Organon Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$19.00 (63.09% Upside)
$19.00 (63.09% Upside)
Blogger Sentiment
Bullish
OGN Sentiment 92%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 1.5%
Last 30 Days ▼ 1.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.63%
12-Months-Change
Fundamentals
Return on Equity
429.85%
Trailing 12-Months
Asset Growth
8.65%
Trailing 12-Months
Company Description
Organon
Organon (OGN) is a global healthcare company that focuses on improving the health and well-being of women. The company operates in the pharmaceuticals sector and offers a diverse portfolio of products primarily targeting reproductive health, heart disease, dermatology, and non-opioid pain management. Organon is dedicated to delivering impactful medicines and solutions, with a strong emphasis on women's health products, biosimilars, and established brands.
---
OGN Company Deck
---
OGN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Organon demonstrated consistent revenue growth and strength in key segments like women's health and biosimilars. However, the company faces significant challenges, including the loss of exclusivity for Atozet, pricing pressures, and substantial one-time costs. The company is actively implementing cost-saving measures to mitigate these challenges.Read More>---
OGN Stock 12 Month Forecast
Average Price Target
$19.00
▲(63.09% Upside)
Technical Analysis
Best Analysts Covering OGN
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+16.01%
reiterated a sell rating 2 months ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +16.01% per trade.
---